No headlines found.
agilon health Sets Date to Report Second Quarter 2024 Financial Results
Business Wire (Tue, 23-Jul 4:00 PM ET)
Globe Newswire (Thu, 18-Jul 11:11 AM ET)
agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer
Business Wire (Wed, 10-Jul 8:00 AM ET)
Globe Newswire (Thu, 20-Jun 11:33 AM ET)
The Portnoy Law Firm Announces Investigation of agilon health, inc. (NYSE: AGL)
Globe Newswire (Mon, 10-Jun 3:57 PM ET)
agilon health Names Jeff Schwaneke New Chief Financial Officer
Business Wire (Wed, 5-Jun 8:00 AM ET)
agilon health to Participate at 44th Annual William Blair Growth Stock Conference
Business Wire (Wed, 29-May 4:00 PM ET)
Newsfile (Wed, 29-May 1:27 PM ET)
Globe Newswire (Mon, 20-May 12:02 PM ET)
Globe Newswire (Mon, 20-May 11:16 AM ET)
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of July 26, 2024, AGL stock price climbed to $6.89 with 2,463,715 million shares trading.
AGL has a beta of -0.90, meaning it tends to be less sensitive to market movements. AGL has a correlation of 0.02 to the broad based SPY ETF.
AGL has a market cap of $2.83 billion. This is considered a Mid Cap stock.
Last quarter Agilon Health reported $2 billion in Revenue and $.01 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.02.
In the last 3 years, AGL stock traded as high as $39.10 and as low as $4.41.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): VTI, IWM, VB, VXF, VBK.
AGL stock has underperformed the market in the last year with a return of -63.2%, while SPY returned +21.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AGL shares. However, AGL has outperformed the market in the last 3 month and 2 week periods, returning +34.3% and +12.0%, while SPY returned +8.5% and -2.2%, respectively. This indicates AGL has been having a stronger performance recently.
AGL support price is $6.44 and resistance is $7.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL stock will trade within this expected range on the day.